ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 111533 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 111533; 2) Community: the network communities that were significantly associated with the response to NSC 111533; 3) Molecule: the relationships between components within communities and NSC 111533; 4) MDR: the compounds that were significantly associated with the NSC 111533.

NSC Compound Enrichment Correlation
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0135714101922724 0.11156353
NSC 726217 Combretastatin A4-analogue 0.0135714101922724 0.12626902
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0139796580235794 0.18898408
NSC 23925 Null 0.0139796580235794 0.022321935
NSC 303861 L-Cysteine analog 0.0139796580235794 0.2325981
NSC 56054 Pseudourea, 2,2'-(9,10-anthrylenedimethylene)bis(2-thio-, dihydrochloride, dihydrate 0.0139796580235794 0.56911775
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0139796580235794 0.28883728
NSC 699145 Null 0.0139796580235794 0.25070302
NSC 716122 Null 0.0139796580235794 0.014242347
NSC 716408 Null 0.0139796580235794 0.27837462
Total:56  Current:18    [First] [Prev] [Next] [Last]